Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on August 8, 2005

Hypertension. 2005
Published online before print August 8, 2005, doi: 10.1161/01.HYP.0000172623.36098.4e
A more recent version of this article appeared on October 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/4/1060    most recent
01.HYP.0000172623.36098.4ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermida, R. C.
Right arrow Articles by Fernández, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermida, R. C.
Right arrow Articles by Fernández, J. R.
Related Collections
Right arrow Clinical Studies

Submitted on April 27, 2005
Revised on May 12, 2005

Differing Administration Time-Dependent Effects of Aspirin on Blood Pressure in Dipper and Non-Dipper Hypertensives

Ramón C. Hermida*; Diana E. Ayala; Carlos Calvo; José E. López; Artemio Mojón; Marta Rodríguez; and José R. Fernández

From the Bioengineering and Chronobiology Laboratories (R.C.H., D.E.A., A.M., J.R.F.), University of Vigo, Campus Universitario, Spain; and Hypertension and Vascular Risk Unit (C.C., J.E.L., M.R.), Hospital Clínico Universitario, Santiago de Compostela, Spain.

* To whom correspondence should be addressed. E-mail: rhermida{at}tsc.uvigo.es.

Abstract--Aspirin is a potent antioxidative agent that reduces vascular production of superoxide, prevents angiotensin II-induced hypertension, and induces NO release. Low-dose aspirin administered at bedtime, but not on awakening, has also been shown to reduce blood pressure, possibly enhancing the nocturnal trough in NO production. Because endothelium-dependent vasodilation is blunted through a decrease in NO release in non-dipper compared with dipper patients, we compared the administration time-dependent influence of aspirin on ambulatory blood pressure in dipper and non-dipper hypertensive subjects. We studied 257 patients with mild hypertension (98 men and 159 women), 44.6±12.5 years of age, randomly assigned to receive 100 mg per day of aspirin either on awakening or at bedtime. Ambulatory blood pressure was measured for 48 hours at baseline and after 3 months of intervention. Blood pressure was slightly elevated after aspirin on awakening (increase of 1.5/1.0 mm Hg in the 24-hour mean of systolic/diastolic blood pressure; P<0.028). A highly significant blood pressure reduction was observed in patients who received aspirin at bedtime (decrease of 7.2/4.9 mm Hg in systolic/diastolic blood pressure; P<0.001). The reduction in nocturnal blood pressure mean was double in non-dippers (11.0/7.1 mm Hg) compared with dippers (5.5/3.3 mm Hg; P<0.001). This prospective trial corroborates the significant administration time-dependent effect of low-dose aspirin on blood pressure, mainly in non-dipper hypertensive patients. The timed administration of low-dose aspirin could thus provide a valuable approach, beyond prevention of cardiovascular disease, in the blood pressure control of patients with mild hypertension. (Hypertension. 2005;46[part 2]:1-9.)


Key words: blood pressure monitoring, ambulatory • hypertension, mild • nitric oxide • circadian rhythm




This article has been cited by other articles:


Home page
HypertensionHome page
J. D. Snoep, M. M.C. Hovens, S. M. Pasha, M. Frolich, H. Pijl, J. T. Tamsma, and M. V. Huisman
Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines
Hypertension, November 1, 2009; 54(5): 1136 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Ying, F. R.C. Giachini, R. C. Tostes, and R. C. Webb
Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation
Cardiovasc Res, July 1, 2009; 83(1): 155 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Med. Inform. Assoc.Home page
F. FitzHenry, J. F. Peterson, M. Arrieta, L. R. Waitman, J. S. Schildcrout, and R. A. Miller
Medication Administration Discrepancies Persist Despite Electronic Ordering
J. Am. Med. Inform. Assoc., November 1, 2007; 14(6): 756 - 764.
[Abstract] [Full Text] [PDF]